US Patent 7541362 Heterocyclic dihydropyrimidine compounds

Patent 7541362 was granted and assigned to Bristol-Myers Squibb on June, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 17 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 17 Sep, 2023

Edits made to:

Infobox (+6 properties)

Infobox

Patent Inventor Names

Heather Finlay0

John Lloyd0

Karnail S. Atwal0

Lin Yan0

Rao S. Bhandaru0

Wayne Vaccaro0

Edits on 15 Sep, 2023

"Add patent abstract"

Golden AI

edited on 15 Sep, 2023

Edits made to:

Article (+473 characters)

Article

Patent abstract

Novel heterocyclic dihydropyrimidine compounds useful as inhibitors of potassium channel function (especially inhibitors of the Kv1 subfamily of voltage gated K+ channels, especially inhibitors Kv1.5 which has been linked to the ultra-rapidly activating delayed rectifier K+ current IKur), methods of using such compounds in the prevention and treatment of arrhythmia and IKur-associated conditions, and pharmaceutical compositions containing such compounds.

Edits on 25 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 25 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=075413620

"Remove leading 0 from patent number"

Golden AI

edited on 25 May, 2023